Research ArticleArticle
Interaction of Tryptamine and Ergoline Compounds with Threonine 196 in the Ligand Binding Site of the 5-Hydroxytryptamine6 Receptor
Frank G. Boess, Frederick J. Monsma Jr., Valerie Meyer, Catherine Zwingelstein and Andrew J. Sleight
Molecular Pharmacology September 1997, 52 (3) 515-523; DOI: https://doi.org/10.1124/mol.52.3.515
Frank G. Boess
Pharma Division, Preclinical Research, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland
Frederick J. Monsma Jr.
Pharma Division, Preclinical Research, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland
Valerie Meyer
Pharma Division, Preclinical Research, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland
Catherine Zwingelstein
Pharma Division, Preclinical Research, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland
Andrew J. Sleight
Pharma Division, Preclinical Research, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Interaction of Tryptamine and Ergoline Compounds with Threonine 196 in the Ligand Binding Site of the 5-Hydroxytryptamine6 Receptor
Frank G. Boess, Frederick J. Monsma, Valerie Meyer, Catherine Zwingelstein and Andrew J. Sleight
Molecular Pharmacology September 1, 1997, 52 (3) 515-523; DOI: https://doi.org/10.1124/mol.52.3.515
Research ArticleArticle
Interaction of Tryptamine and Ergoline Compounds with Threonine 196 in the Ligand Binding Site of the 5-Hydroxytryptamine6 Receptor
Frank G. Boess, Frederick J. Monsma, Valerie Meyer, Catherine Zwingelstein and Andrew J. Sleight
Molecular Pharmacology September 1, 1997, 52 (3) 515-523; DOI: https://doi.org/10.1124/mol.52.3.515
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement